Connect Biopharma Holdings Limited Current Contract Assets
Connect Biopharma Holdings Limited (CNTB) had Current Contract Assets of $3.56 million as of 2024-06-30, per its 6-K filed 2024-09-05.
Discontinued › Notes
ifrs-full:CurrentContractAssets · last filed 2024-09-05
- 2024-06-30: Current Contract Assets $3.56M.
- 2023-12-31: Current Contract Assets $0.00.
| Period end | Current Contract Assets |
|---|---|
| 2024-06-30 | $3.56M 6-K · filed 2024-09-05 |
| 2023-12-31 | $0.00 6-K · filed 2024-09-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |